References
- National Institutes of Health. National Institutes of Health Consensus Development Conference Statement: liver transplantation: June 20–23, 1983. Hepatology 1984;4(1 Suppl): 107–10S
- Scharschmidt BF. Human liver transplantation: analysis of data on 540 patients from four centers. Hepatology 1984; 4(1 Suppl): 95–101S
- Rosen HR, Shackleton CR, Martin P. Indications for and timing of liver transplantation. Med Clin North Am 1996; 80(5):1069–102
- Fabry T, Klion F. Liver transplantation: selection of patients for referral. In: Fabry TL, Klion FM, eds. Guide to liver transplantation. New York: Igaku-Shoin, 1992: 79–101
- Lake JR. Changing indications for liver transplantation. Gastroenterol Clin North Am 1993; 22(2): 213–29
- Bories P, Garcia Compeau D, Michel H, et al. The treatment of refractory ascites by the LeVeen shunt: a multi-centre controlled trial (57 patients). J Hepatol 1986; 3(2):212–8
- Ferral H, Bjarnason H, Wegryn SA, et al. Refractory ascites: early experience in treatment with transjugular intrahepatic portosystemic shunt. Radiology 1993; 189(3): 795–801
- Ochs A, Rossle M, Haag K, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995; 332(18): 1192–7 [Erratum, N Engl J Med 1995;332(23): 1587]
- Stiegmann GV, Goff JS, Michaletz-Onody PA, et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med 1992; 326(23): 1527–32
- Jutabha R, Jensen DM. Management of upper gastrointestinal bleeding in the patient with chronic liver disease. Med Clin North Am 1996; 80(5):1035–68
- Penn I. Hepatic transplantation for primary and metastatic cancers of the liver. Surgery 1991; 110(4): 726–34; discussion 734–5
- Lucey MR, Merion RM, Henley KS, et al. Selection for and outcome of liver transplantation in alcoholic liver disease. Gastroenterology 1992; 102(5):1736–41
- Belle A, Beringer K, Murphy J, et al. The Pitt-UNOS liver transplant registry. In: Clinical transplants. Los Angeles: UCLA Tissue Typing Laboratory, 1992: 17
- Stieber AC, Gordon RD, Todo S, et al. Liver transplantation in patients over sixty years of age. Transplantation 1991; 51(1):271–3
- O'Grady JG, Alexander GJ, Hayllar KM, et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97(2):439–45
- Bonsel GJ, Klompmaker IJ, van't Veer F, et al. Use of prognostic models for assessment of value of liver transplantation in primary biliary cirrhosis. Lancet 1990; 335(8688):493–7
- Di Bisceglie AM. Liver transplantation for hepatitis C: the promise and the challenge. (Editorial) Hepatology 1995; 22(2):660–2
- Bizollon T, Palazzo U, Ducerf C, et al. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation. Hepatology 1997; 26(2):500–4
- Harren P, Rudow DL, Teperman LW, et al. Incidence and treatment of recurrent hepatitis C after liver transplantation. J Transpl Coord 1996; 6(1):24–7
- Gish RG, Lee AH, Keeffe EB, et al. Liver transplantation for patients with alcoholism and end-stage liver disease. Am J Gastroenterol 1993; 88(9):1337–42